NextShark Ventures is proud to welcome Remission Biotech as the latest addition to its portfolio of companies redefining the ...

For more than two decades, scientists have been working to develop a range of animal and agricultural products, foods, industrials, and pharmaceuticals made with the help of genetic modification ...

Unnatural Products, a Santa Cruz-based biotech company founded by UC Santa Cruz alumni Cameron Pye and Joshua Schwochert breaks new ground in the biotech landscape.

Developing countries could exploit traditional medicine to kick-start biotech, but only if their products measure up to the demands of Western regulators. Paroma Basu reports.

Eric Park, JinYoung Bio’s President, says the biotechnology-based approach costs more than traditional manufacturing but leads to higher-quality products.

The SPDR S&P Biotech ETF (XBI) made its debut on 01/31/2006, and is a smart beta exchange traded fund that provides broad exposure to the Health Care ETFs category of the market. What Are Smart Beta ...

Via an ad hoc committee, the Committee on Future Biotechnology Products and Opportunities to Enhance Capabilities of the Biotechnology Regulatory System, NAS developed this report through several ...

Many of our traditional foods are products of natural mutations or genetic recombinations. Nature is constantly mutating genes and even moving them from one species to another. With biotechnology, ...

Now's the time to invest in biotech, according to VCs who've analyzed 1,227 early-stage biotech startups. Here's why they're so sure.

New Deloitte Report Details the Potential of Biotechnology to Bring New Life to People, Products and the PlanetThe report also cautions the urgency of the challenges we face — from climate ...